Get in Touch

We conducted a risk and opportunity assessment of undergoing joint HTA initiative for a GT ​

  • Access Strategy
We really appreciated P4A’s support as we tried to navigate this non-transparent pathway – they provided invaluable insights that helped us with our decision-making
Global Program​ Leader​

Client Challenge

Seeking to understand the benefits and risks of undergoing Joint HTA routes for a GT​

A global GT company wanted to understand the process involved in the BeNeLuxA and FINOSE initiatives versus individual country HTA processes​

They wanted to know the opportunities and challenges for their late-stage GT would like face through each pathway and which would allow the optimal route to access​

P4A Solution

P4A provided a comprehensive overview of the pathways and recommended the optimal route to access

We mapped out each pathway, using secondary and primary research, to provide an overview of: ​
  • The process involved, with timelines  ​
  • Key decision makers ​
  • Assessment criteria ​
  • Opportunities and risks with each pathway specific to the GT ​

The Successful Outcome​

  • Outlined expectations on how the joint HTA would appraise the evidence package and the likely outcome, including a risk assessment vs. going to individual country processes​
  • Identify if joint HTA route is a no-go vs. individual country HTA pathways for each scope market ​
  • Advise on strategic levers that can be used to optimise joint HTA outcomes​
  • Develop phasing considerations for involvement of BeNeLuxA and FINOSE​

Need more details?

Do you want to learn more about the successful outcome for this case study? Are you interested in P4A Services or just want to say Hi?

get in touch

Explore other case studies

Understand evidence requirements beyond clinical trial data for launching an orphan drug in Türkiye & the GCC

  • Access Strategy

Optimising the PRMA potential of an orphan oncology asset in EU4 + UK and Japan

  • Price Optimisation, Access Strategy
p4a-logo-small-retina-white

We are award winning global experts in access for orphan drugs and Cell and Gene Therapies.

Twitter Instagram Youtube Linkedin

About

Services

Insights

Case Studies

Contact

  • Aramislaan 88,
  • 6213BV Maastricht, Netherlands
  • +31 6 55 88 71 96
  • contact@partners4access.com

P4A Services

For all access and Rare Disease related overview enquiries